Clarius Mobile Health Corp. — FDA PCCPs
Clarius Mobile Health Corp. holds 4 FDA-authorized PCCPs in this tracker, 3 AI/SaMD. Here is the full list, newest first.
- K253593Clarius Ejection Fraction AIClarius Mobile Health Corp.2026-03-02AI hardwareI/O expansion
- K250226Clarius Median Nerve AIClarius Mobile Health Corp.2025-05-08AI/SaMDRetraining
- K243853Clarius Prostate AIClarius Mobile Health Corp.2025-04-16AI/SaMDRetraining
- K233955Clarius OB AIClarius Mobile Health Corp.2024-06-14AI/SaMDArchitecture change
Other companies
Want the monitoring teardown?
We read the Clarius Mobile Health Corp. PCCPs in this list, then map the post-market monitoring that its modification protocol requires, including the deployment-period evidence most teams can't reconstruct at modification time. Sentir is the independent system of record that produces it.
Book a callSource: U.S. FDA public records (openFDA 510(k)/De Novo databases and accessdata.fda.gov). PCCP type and category are editorial classifications based on public documents, not official FDA designations.
This page is a factual summary of public FDA records. Sentir Health is not affiliated with or endorsed by the named companies or the U.S. Food and Drug Administration. Spot an error? Request a correction.